Indivior Pharmaceuticals, Inc 6-K, filed Mar 13, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K
2024-03-13
For: 2024-03-13
View Original
Added on
April 10, 2026
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on March 13, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: March 13, 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ☐
|
|
EXHIBIT INDEX
|
Exhibit
No.
|
Description
of Exhibit
|
|
99.1
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: March 13,
2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
|
Exhibit
99.1
|
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
The Company announces that it received notification on March 13,
2024, that Kathryn Hudson, a PDMR, and Paul Hudson, a person
closely associated with Kathryn Hudson, sold a total of 2,750
Ordinary Shares of US$0.50 each in the Company ('Shares') on March
13, 2024 at a price of £16.49 per Share.
Following this transaction, Kathryn Hudson has a beneficial
interest in 58,391 Shares in the Company.
Further information is provided below in accordance with the UK
Market Abuse Regulation.
Kathryn Hudson
Company Secretary
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
|
a)
|
Name
|
Kathryn Hudson
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
PDMR - Company Secretary
|
|
|
b)
|
Initial notification /Amendment
|
Initial notification
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
Indivior PLC
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£16.49
|
1,900
|
||
|
d)
|
Aggregated information
- Volume
- Price
- Total
|
n/a
|
|
|
e)
|
Date of the transaction
|
March 13, 2024
|
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
|
a)
|
Name
|
Paul Hudson
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
Person Closely Associated with Kathryn Hudson,
Company Secretary
|
|
|
b)
|
Initial notification /Amendment
|
Initial notification
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
Indivior PLC
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£16.49
|
850
|
||
|
d)
|
Aggregated information
- Volume
- Price
- Total
|
n/a
|
|
|
e)
|
Date of the transaction
|
March 13, 2024
|
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|
Indivior PLC's Legal Entity Identifier code is
213800V3NCQTY7IED471.